Sky Century Investment (SKYI) Accounts Payables (2013 - 2026)
Sky Century Investment (SKYI) posted quarterly Accounts Payables of $2432.0 for Q2 2026, down 94.81% year-over-year from $46847.0 in Q2 2025, and down 64.11% quarter-over-quarter from $6777.0 in Q1 2026.
Sky Century Investment (SKYI) Accounts Payables (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Accounts Payables for 5 consecutive years, with $2432.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Accounts Payables fell 94.81% year-over-year to $2432.0; the TTM figure through May 2026 stood at $2432.0 (down 94.81% YoY), while the FY2025 annual figure was $28794.0, changed 0.36% from the prior year.
- Accounts Payables retreated to $2432.0 in Q2 2026 per SKYI's latest filing, from $6777.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $46847.0 in Q2 2025 and bottomed at $2432.0 in Q2 2026.
- Historically, Accounts Payables has averaged $22814.5 across 3 years, with a median of $25967.0 in 2025.
- Annual changes were most pronounced in 2025 — Accounts Payables fell 0.36% — and 2026, when it sank 94.81%.
- Sky Century Investment's Accounts Payables stood at $28897.0 in 2024, then slipped by 19.92% to $23140.0 in 2025, then tumbled by 89.49% to $2432.0 in 2026.
- Business Quant data shows SKYI's Accounts Payables at $2432.0 in Q2 2026, $6777.0 in Q1 2026, and $23140.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 2,432.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 2,432.00 |
| Feb 28, 2026 | 6,777.00 |
| Nov 30, 2025 | 23,140.00 |
| Aug 31, 2025 | 28,794.00 |
| May 31, 2025 | 46,847.00 |
| Aug 31, 2024 | 28,897.00 |
| Aug 31, 2014 | 14,880.00 |
| May 31, 2014 | 6,450.00 |
| Feb 28, 2014 | 2,000.00 |
| Nov 30, 2013 | 2,300.00 |
| Aug 31, 2013 | 2,500.00 |
| May 31, 2013 | 4,000.00 |